Cargando…
EGFR突变非小细胞肺癌免疫治疗相关研究进展
Targeted therapy and immunotherapy are important treatments for non-small cell lung cancer (NSCLC). At present, the clinical and basic research of epidermal growth factor receptor (EGFR) mutation NSCLC is still in the exploratory stage, needing to optimize the efficacy, combination, sequence and dos...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717865/ https://www.ncbi.nlm.nih.gov/pubmed/31451147 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.08.11 |